The largest database of trusted experimental protocols

Ro4929097

Manufactured by Merck Group
Sourced in United States

RO4929097 is a chemical compound manufactured by Merck Group. It is primarily used as a research tool in laboratory settings. The core function of RO4929097 is to serve as a reference standard or analytical standard for various research and development applications. No further details on the intended use or applications of this product are provided.

Automatically generated - may contain errors

3 protocols using ro4929097

1

Notch and IKK Inhibitor Screening in SCC13 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following compounds were used for inhibition of gamma-secretase-NOTCH and Inhibitor-kappaB Kinase in experiments: DAPT (https://pubchem.ncbi.nlm.nih.gov/compound/dapt), catalog D5942, Sigma Aldrich, St Louis, MO); RO4929097 (https://pubchem.ncbi.nlm.nih.gov/compound/49867930#section=Top), catalog No. ADV465749148, Sigma Aldrich, St Louis, MO); Wedelolactone (Wedelolactone#section=Top">https://pubchem.ncbi.nlm.nih.gov/compound/Wedelolactone#section=Top), catalog #56639, Sigma Aldrich, St Louis, MO).
SCC13 cells were treated with two different Notch inhibitors, DAPT or R04929097 in different doses and measured by FACS analysis. 10μM Wedelolactone was used to treat SCC13 cells for 24 hours. Cells then harvested and stained with CD133 antibody for FACS analysis. Spheres or colonies were counted after 5 days drug treatment. Medium with drug were changed every three days.
+ Open protocol
+ Expand
2

Inhibiting Exosomes and Notch Signaling in Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
HUVECs and human osteosarcoma cell lines (U2OS and 143B) were purchased from China Centre for Type Culture Collection (CCTCC; Wuhan, China). These cells were cultured in Dulbecco’s Modified Eagle’s medium (DMEM; Gibco, Camarillo, CA, USA) containing 10% fetal bovine serum (FBS; Gibco) and 1% penicillin/streptomycin (Solarbio, Beijing, China). Cells were cultured in a constant temperature incubator at 37°C and 5% CO2.
HUVECs were incubated with 10 μM GW4869 (exosome inhibitor; Sigma-Aldrich, St. Louis, MO, USA) or 0.1% DMSO for 24 h. GW4869 is a cell-permeable, noncompetitive N-Smase (neutral sphingomyelinase) inhibitor. GW4869 blocks the ceramide-mediated sprouting of multivesicular bodies, thereby inhibiting the release of exosomes from multivesicular bodies. Thus, GW4869 is a commonly used as an exosome inhibitor [15 ]. For co-culture, U2OS and 143B cells were incubated with the HUVEC supernatant, HUVEC-derived exosomes (VECs-Exo) or PBS. U2OS and 143B cells were treated with 1 mM RO4929097 (γ secretase inhibitor; Sigma-Aldrich) for 24 h. The Notch receptor is cleaved by furin convertase, ADAM and γ-secretase to produce Notch intracellular domain. The Notch intracellular domain is released to the nucleus and then activates the transcription of related genes [16 (link)]. Thus, RO4929097 blocks the Notch signaling pathway by inhibiting the activity of γ secretase.
+ Open protocol
+ Expand
3

Notch Signaling Pathway Regulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dulbecco’s modified Eagle’s medium (DMEM), antibiotics (penicillin and streptomycin), and fetal bovine serum (FBS) were purchased from Invitrogen (Thermo Fisher Scientific, Inc., Waltham, MA, USA). The primary antibodies were obtained from Abcam (Cambridge, MA USA), which included anti-Notch2, anti-Hey1, anti-Snail, anti-N-cadherin, anti-Twist, anti-E-cadherin, and anti-GAPDH antibodies. RO4929097 and DMSO (dimethyl sulfoxide) were purchased from Sigma-Aldrich (St. Louis, MO, USA). The Cell Counting Kit-8 (CCK-8) was obtained from Dojindo (Kumamoto, Japan) and all other chemicals were from Sigma-Aldrich (St. Louis, MO, USA) unless otherwise indicated.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!